Detection and quantification of embolic particles during percutaneous coronary intervention to stable plaque: It correlates to coronary flow dynamics and myocardial damage

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 3, 2007, Pages 425-431

  Okamura, Atsunori ^a   Ito, Hiroshi ^a   Iwakura, Katsuomi ^a   Kawano, Shigeo ^a   Kurotobi, Toshiya ^a   Date, Motoo ^a   Inoue, Koichi ^a   Ogihara, Toshio ^b   Fujii, Kenshi ^a  

^a Sakurabashi Watanabe Hospital   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Coronary microvascular dysfunction; Embolization; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TICLOPIDINE; TROPONIN T;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY STENT; EMBOLISM; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; MICROVASCULATURE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POINT OF CARE TESTING; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CREATINE KINASE, MB FORM; ECHOCARDIOGRAPHY, DOPPLER; EMBOLISM; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RESEARCH DESIGN; SIGNAL PROCESSING, COMPUTER-ASSISTED; STENTS; TREATMENT OUTCOME; TROPONIN T; VASCULAR RESISTANCE;

EID: 33847413571     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20971     Document Type: Article

References (23)

1. Hokimoto S, Saito T, Noda K, Date H, Ishibashi F, Nakamura S, Miyata K, Takayanagi S, Oshima S. Relation between coronary thrombus and angiographic no-flow during primary angioplasty in patients with acute myocardial infarction. Jpn Circ J 1999;63:849-853.
2. Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, Nagata S, Hori M. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002;106:1672-1677.
3. Angelini A, Rubartelli P, Mistrorigo F, Della Barbera M, Abbadessa F, Vischi M, Thiene G, Chierchia S. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 2004;110:515-521.
4. Herrmann J, Haude M, Lerman A, Schulz R, Volbracht L, Ge J, Schmermund A, Wieneke H, von Birgelen C, Eggebrecht H, Baumgart D, Heusch G, Erbel R. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001;103:2339-2345.
5. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027-1032.
6. Kern MJ, Puri S, Bach RG, Donohue TJ, Dupouy P, Caracciolo EA, Craig WR, Aguirre F, Aptecar E, Wolford TL, Mechem CJ, Dubois-Rande JL. Abnormal coronary flow velocity reserve after coronary artery stenting in patients: Role of relative coronary reserve to assess potential mechanisms. Circulation 1999;100:2491-2498.
7. Padayachee TS, Gosling RG, Bishop CC, Burnand K, Browse NL. Monitoring middle cerebral artery blood velocity during carotid endarterectomy. Br J Surg 1986;73:98-100.
8. Okamura A, Ito H, Iwakura K, Kawano S, Inoue K, Maekawa Y, Ogihara T, Fujii K. Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2005;45:212-215.
9. Bahrmann P, Figulla HR, Wagner M, Ferrari M, Voss A, Werner GS. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart 2005;91:1186-1192.
10. Sambuceti G, Marzilli M, Marraccini P, Schneider-Eicke J, Gliozheni E, Parodi O, L'Abbate A. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 1997;95:2652-2659.
11. Stone GW, Brodie BR, Griffin JJ, on behalf of the Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Improved short-term outcomes of primary coronary stenting compared to primary balloon angioplasty in acute myocardial infarction at experienced centers: the PAMI study group experience. J Interv Cardiol 1999;12:101-108.
12. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, Ito H, Kitabatake A, Sato T, Kamada T. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 1986;250:H509-H518.
13. Hori M, Tamai J, Kitakaze M, Iwakura K, Gotoh K, Iwai K, Koretsune Y, Kagiya T, Kitabatake A, Kamada T. Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol 1989;257:H244-H251.
14. Yamamoto K, Ito H, Iwakura K, Kawano S, Ikushima M, Masuyama T, Ogihara T, Fujii K. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol 2002;40:1755-1760.
15. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994;89:2514-2518.
16. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-660.
17. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, Nishikawa N, Higashino Y, Fujii K, Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-1199.
18. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-640.
19. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
20. Kern MJ, Bach RG, Mechem CJ, Caracciolo EA, Aguirre FV, Miller LW, Donohue TJ. Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation, and coronary artery disease. J Am Coll Cardiol 1996;28:1154-1160.
21. Wolford TL, Donohue TJ, Bach RG, Drury JH, Caracciolo EA, Kern MJ, Miller LW. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries. Circulation 1999;99:626-632.
22. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15:459-474.
23. Islam MA, Blankenship JC, Balog C, Iliadis EA, Lincoff AM, Tcheng JE, Califf RM, Topol EJ, EPISTENT Investigators. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). Am J Cardiol 2002;90:916-921.